Related Articles
Formoterol treatment down-regulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats
The AP-1/NF-κB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia
Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models
Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia
Tumour growth and nitrogen metabolism in the host (Review).